Form 8-K/A





Washington, D.C. 20549




Amendment No. 1




Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 4, 2015




(Exact name of registrant as specified in charter)




Delaware   1-16789   04-3565120

(State or Other Jurisdiction

of Incorporation)



File Number)


(IRS Employer

Identification No.)

51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453

(Address of Principal Executive Offices) (Zip Code)

(781) 647-3900

(Registrant’s telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Explanatory Note

This Amendment No. 1 on Form 8-K/A (this “Form 8-K/A”) amends the Current Report on Form 8-K of Alere Inc., dated November 4, 2015 (the “Original Form 8-K”). This Form 8-K/A is being filed to make corrections relating to the allocation of cost of net revenue between segments included in the non-GAAP reconciliation statements included in Exhibit 99.1 to the Original Form 8-K, as described in more detail in Item 2.02 below.


Item 2.02. Results of Operations and Financial Condition.

On November 4, 2015, Alere Inc. (the “Company”) announced its financial results for the fiscal quarter ended September 30, 2015. The press release issued in connection with the announcement, which was furnished as Exhibit 99.1 to the Original Form 8-K, contained errors to the table captioned “Reconciliations of Gross Profit/Margin to Non-GAAP Adjusted Gross Profit/Margin – Professional Diagnostics Segment” for the three months ended September 30, 2015. Specifically, the following adjustments are being made to that table (amount in thousands):


     Amounts reported in Original Form 8-K     Corrected Amounts  

Cost of net revenue

   $ 292,156      $ 308,976   

Non-GAAP adjusted cost of net revenue

   $ 275,174      $ 291,994   

Non-GAAP adjusted gross profit

   $ 305,254      $ 288,434   

Non-GAAP adjusted gross margin

     52.6     49.7

The following is this table presented in its entirety:


Professional Diagnostics Segment    Three Months Ended
September 30, 2014 (1)
    Three Months Ended
June 30, 2015
    Three Months Ended
September 30, 2015

Net product sales and services revenue

   $ 628,012         $ 598,817         $ 579,998      

Adjustment related to acquired software license contracts

     324           200           430      










Non-GAAP adjusted net product sales and services revenue

     628,336           599,017           580,428      










Cost of net revenue

     329,013           312,068           308,976      

Less adjustments:


Amortization of acquisition-related intangible assets

     15,659           13,112           16,133      

Stock-based compensation expense

     291           287           326      

Restructuring charges

     5,654           897           523      










Non-GAAP adjusted cost of net revenue

     307,409           297,772           291,994      










Non-GAAP adjusted gross profit/margin

   $ 320,927         51.1   $ 301,245         50.3   $ 288,434         49.7






















(1)  Restated to reflect the impact of discontinued operations and the impact of a change in segment reporting

The information provided under this Form 8-K/A (including Exhibit 99.1) is “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.


- 2 -


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: November 5, 2015     By:  

/s/ James F. Hinrichs

    Name: James F. Hinrichs
    Title: Executive Vice President & Chief Financial Officer


- 3 -